FDA approves treatment for chronic weight management in pediatric patients aged 12 years and older

[FDA]

The U.S. Food and Drug Administration has approved a supplemental indication for Qsymia (phentermine and topiramate extended-release capsules) for chronic weight management in pediatric patients aged 12 years and older who are obese, defined as a body mass index (BMI) of 95th percentile or greater w


Baca selengkapnya di : http://www.fda.gov...